glutathione pathway to triple negative cancer Ferroptosis heterogeneity in triple-negative breast reveals an innovative immunotherapy combination strategy Recent advances in targeted strategies
Recent advances in targeted strategies for triple negative breast cancer Journal of Hematology & Oncology Springer Nature Link Activation of the eIF2 ATF4 axis drives triple negative breast cancer radioresistance by promoting glutathione biosynthesis ScienceDirect Targeting the redox programmed cell death axis in breast cancer: from molecular mechanisms to therapeutic resistance Cell Death Discovery Adipocyte derived glutathione promotes obesity related breast cancer by regulating the SCARB2 ARF1 mTORC1 complex: Cell Metabolism
Pay in 4 interest-free payments of $5.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



